An inhibitor of tau aggregation
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

TRx0237 (mesylate)

Item No. 34307

Technical Information
Formal Name
N3,N3,N7,N7-tetramethyl-10H-phenothiazine-3,7-diamine, dimethanesulfonate
CAS Number
1236208-20-0
Synonyms
  • Hydromethylthionine
  • Leucomethylene Blue
  • Leukomethylthioninium dihydromesylate
  • LMTM
Molecular Formula
C16H19N3S • 2CH3SO3H
Formula Weight
Purity
≥95%
A solid
DMSO: 5 mg/mlDMSO:PBS (pH 7.2) (1:4): 0.20 mg/ml
λmax
237, 264, 656 nm
SMILES
O=S(O)(C)=O.CN(C)C1=CC=C2NC3=CC=C(N(C)C)C=C3SC2=C1.O=S(O)(C)=O
InChi Code
InChI=1S/C16H19N3S.2CH4O3S/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;2*1-5(2,3)4/h5-10,17H,1-4H3;2*1H3,(H,2,3,4)
InChi Key
SPCMQFLNOVTUBM-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    TRx0237 is an inhibitor of tau aggregation.1 It inhibits tau-tau binding (IC50 = 238 µM) and tau aggregation in 3T6H cells expressing human tau (EC50 = 0.19 µM). TRx0237 (5 and 15 mg/kg) increases hippocampal acetylcholine (ACh) and synaptophysin levels, as well as increases mitochondrial complex IV activity, decreases tau pathology, and reverses deficits in spatial learning in the L1 transgenic mouse model of Alzheimer’s disease.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Harrington, C.R., Storey, J.M.D., Clunas, S., et al. Cellular models of aggregation-dependent template-directed proteolysis to characterize tau aggregation inhibitors for treatment of Alzheimer disease. The Journal of Biological Chemisty 290(17), 10862-10875 (2015).

    2. Riedel, G., Klein, J., Niewiadomska, G., et al. Mechanisms of anticholinesterase interference with tau aggregation inhibitor activity in a tau-transgenic mouse model. Curr. Alzheimer Res. 17(3), 285-296 (2020).